We're pleased to join industry leaders and researchers in Singapore on April 29-30. Don't miss the presentation and panel discussion by our Global Scientific Affairs Department Manager, Caroline Montelius.
Why specific probiotic strains matter more than ever
For a long time, probiotics were treated as interchangeable, but that era is coming to an end. As microbiome science has advanced, it has become increasingly clear that probiotic effects are strain-specific. Two strains from the same species can behave very differently in the body, influencing distinct biological pathways and delivering very different outcomes. This shift is redefining how brands formulate, position, and validate their products in an increasingly evidence-driven market.
At the same time, consumer expectations are rising. Today’s consumers are not simply looking for general wellness support; they are seeking targeted, clinically supported solutions that align with their personal health needs. Trust is often built on specificity - knowing what is in a product, what it does, and why.
One of the most important developments underpinning this shift is a deeper understanding of how health systems interact. Digestive health, immune resilience, cognitive function, metabolic balance, and physical performance are often treated as separate categories. In reality, they are tightly interconnected, and many of these connections converge in the gut.
This creates a new opportunity for brands. Rather than formulating around isolated symptoms, they can now target underlying biological systems using well-characterised probiotic strains with defined mechanisms and outcomes.
Probi’s portfolio reflects this systems-based approach, targeting nine distinct health areas with clinically documented probiotic strains focusing on specific health outcomes within a specific area or target group.
At the centre of this approach is Lactiplantibacillus plantarum 299v (LP299V®). This is one of the most extensively studied probiotic strains and the most clinically documented L.plantarum strain globally with over 290 published scientific articles and 80 clinical trials. While it is widely recognised for its role in supporting digestive health by helping to alleviate irritable bowel syndrome symptoms, and restoring balance after antibiotic use, it also increases microbial diversity, thereby extending its reach far beyond the gut.
LP299V has been shown to enhance iron absorption, improving iron status while reducing the gastrointestinal side effects often associated with iron supplementation. This makes it highly relevant for women’s health especially during pregnancy, where iron needs are increased and both efficacy and tolerability are critical.
LP299V also plays a role in metabolic and cardiovascular health, supporting vascular function, metabolism, and blood pressure regulation. In parallel, research in physically active populations demonstrates improvements in VO₂ max, endurance, and perceived energy, alongside better digestive resilience during physical stress.
This illustrates that a single, well-documented strain can act as a platform for multiple health categories, enabling brands to build cohesive product portfolios grounded in consistent science.
While LP299V demonstrates breadth, other strains offer more targeted functionality. Lactiplantibacillus plantarum HEAL9 (HEAL9®), for example, has been found to address the growing demand for solutions targeting the gut-brain axis.
Clinical studies show that HEAL9 supports cognitive performance, memory, and attention, while also influencing emotional well-being by reducing stress markers such as cortisol and improving sleep quality. These outcomes reflect the complex, bidirectional communication between the gut and the brain. Interestingly, when combined with Lacticaseibacillus paracasei 8700:2 (L.paracasei 8700:2™), it also contributes to immune resilience, reducing the incidence and severity of common colds and supporting recovery from infections. This dual functionality highlights how strain combinations can be used to address complex areas such as immune health where both an upregulation and dampening effect of bodily processes are needed, HEAL9 acts to downregulate proinflammation while L. paracasei 8700:2 enhances functions to create a strong and resilient immune system.
As consumers move through different life stages, their health priorities evolve, and strain specificity allows brands to respond with precision.
In the context of healthy ageing, a combination of HEAL9, L. paracasei 8700:2, and Lactiplantibacillus plantarum HEAL19 (HEAL19™) has been shown to support bone health, reducing bone loss over time, particularly important during menopause. This creates opportunities to develop targeted solutions for ageing populations, where maintaining mobility and long-term vitality is a priority.
Similarly, metabolic health, which is often framed around individual metrics such as blood sugar or cholesterol, is increasingly understood as a cluster of interconnected risk factors. By combining LP299V with L. paracasei 8700:2, brands can address this cluster more holistically, supporting cardiovascular function, weight management, and inflammatory balance within a single product concept.
Strain specificity also enables expansion into adjacent categories that were not traditionally associated with probiotics.
In oral health, Streptococcus salivarius M18 (BLIS M18™) plays a role in maintaining a balanced oral microbiota, supporting gum and dental health. Meanwhile, Streptococcus salivarius K12 (BLIS K12™) has been extensively studied for its benefits in ear, nose, and throat (ENT) health, as well as in reducing halitosis (bad breath). These strains open up entirely new format and positioning opportunities ranging from lozenges and chewables to daily oral care solutions that allow brands to extend probiotic innovation beyond capsules and into more diverse consumer touchpoints.
What emerges from this portfolio is not a collection of isolated ingredients, but a toolkit for precision nutraceutical design. By focusing on nine health areas, our clinically documented probiotic strains contribute with clearly defined functions ranging from digestive, sports and nutrient absorption to bone and ENT health. Together, they enable brands to move from single-benefit products to integrated health solutions that reflect how consumers experience well-being.
The probiotic category is becoming more sophisticated, more evidence-driven, and more outcome-focused. In this environment, strain specificity is no longer a differentiator but a key requirement offering scientific precision into products that are clearly positioned, clinically credible and relevant across life stages and lifestyles
For more insight into our range of strain-specific probiotics, please contact our team by visiting www.probi.com.